OakChart

Universal Health Services Inc

UHSHealthcare·Medical Care Facilities·USA·Large·NYSE·Nov 11 • 12:39 PM ET

194.52-0.89 (-0.45%)
2026-11-11 18:39 CET
Market cap
11,516.74 USD m
Revenue, TTM
18,352.59 USD m
Net income, TTM
1,461.75 USD m
Free cash flow, TTM
1,115.23 USD m
EPS diluted, TTM
23.92
P/E
8.13
Compare

Price

UHS against its 20, 50 and 200-day averages
2050200beat
140.00160.00180.00200.002.4M4.9MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26UHSclose 194.5220-day 186.0850-day 180.12200-day 176.53194.5252w low

21.0% under the 52-week high of 246.33 on 26 Nov 2025. 52-week low 140.08 on 8 Jun 2026. Last 15 sessions, 21.1% high to low

Profile

UHS
52-week range, 51% of the way up
140.08246.32

Universal Health Services, Inc. engages in providing hospital and healthcare services. It operates through the following segments: Acute Care Hospital Services, Behavioral Health Care Services, and Other. The Acute Care Hospital Services segment includes hospitals, freestanding emergency departments, and ambulatory centers. The Behavioral Health Care Services segment offers treatment programs for depression, anxiety, psychotic diagnoses, bipolar disorder, post-traumatic stress disorder, and neurorehabilitation. The Other segment consists of centralized services such as information technology, purchasing, reimbursement, accounting and finance, taxation, legal, advertising, and design and construction. The company was founded by Alan B. Miller in 1979 and is headquartered in King of Prussia, PA.

IndexS&P 500, RUI
Employees101500
IPOJul 09, 1981
Beta1.09
ATR, 14d6.85
Rel volume0.40
Short float5.22%
Insider own17.21%
Inst own93.33%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap11.21B
Enterprise Value17.37B
Income1.46B
Sales18.35B
Book/sh131.77
Cash/sh2.93
Dividend Est.0.82 (0.42%)
Dividend TTM0.80 (0.41%)
Dividend Ex-DateSep 01, 2026
Dividend Gr. 3/5Y0.00% 31.95%
Payout3.46%
Employees101500
IPOJul 09, 1981

Ratios

P/E8.13
Forward P/E8.46
PEG1.86
P/S0.61
P/B1.48
P/C66.44
P/FCF10.05
EV/EBITDA6.55
EV/Sales0.95
Quick Ratio1.28
Current Ratio1.37
Debt/Eq0.81
LT Debt/Eq0.79
Option/ShortYes / Yes

Earnings

EPS (ttm)23.92
EPS next Y22.98
EPS next Q5.63
EPS this Y3.03%
EPS next Y2.60%
EPS next 5Y4.55%
EPS past 3/5Y36.20% 15.93%
Sales past 3/5Y9.03% 8.48%
EPS Y/Y TTM13.14%
Sales Y/Y TTM8.00%
EPS Q/Q-10.91%
Sales Q/Q5.30%
EarningsOct 27 AMC
EPS/Sales Surpr.0.54% 0.51%

Ownership

Insider Own17.21%
Insider Trans0.00%
Inst Own93.33%
Inst Trans2.06%
ROA8.99%
ROE19.80%
ROIC10.74%
Gross Margin10.85%
Oper. Margin10.85%
Profit Margin7.96%
SMA204.54%
SMA508.00%
SMA20010.20%
Trades-

Technical

Shs Outstand50.40M
Shs Float48.79M
Short Float5.22%
Short Ratio3.58
Short Interest2.55M
52W High246.32 -21.03%
52W Low140.08 38.87%
Volatility3.78% 3.65%
ATR (14)6.85
RSI (14)60.29
Beta1.09
Rel Volume0.40
Avg Volume712.52K
Volume145,322

Performance

Perf Week-0.99%
Perf Month8.67%
Perf Quarter13.62%
Perf Half Y13.75%
Perf YTD-10.78%
Perf Year-13.32%
Perf 3Y49.37%
Perf 5Y49.32%
Perf 10Y63.82%
Recom2.48
Target Price195.75
Prev Close195.41
Price194.52
Change %-0.45%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jul 08, 2026DowngradeBBarclaysOverweight → Equal Weight$179-8.0%
Jun 01, 2026ResumedWWells FargoEqual Weight$165-15.2%
Apr 29, 2026DowngradeRRaymond JamesOutperform → Mkt Perform
Jan 07, 2026DowngradeWWells FargoOverweight → Equal Weight$235+20.8%
Nov 03, 2025UpgradeRRaymond JamesMkt Perform → Outperform$270+38.8%
Oct 14, 2025ResumedGGoldmanNeutral$219+12.6%
Jul 16, 2025DowngradeBBofA SecuritiesNeutral → Underperform$185-4.9%
Apr 15, 2025DowngradeRRobert W. BairdOutperform → Neutral$224+15.2%
Mar 26, 2025InitiatedMMorgan StanleyEqual-Weight$200+2.8%
Feb 03, 2025UpgradeCCantor FitzgeraldNeutral → Overweight

Peers

Mkt cap
TickerCompanyMkt cap
THCTenet Healthcare Corp22.84B
HCAHCA Healthcare Inc104.24B
ACHCAcadia Healthcare Company Inc3.57B
CYHCommunity Health Systems Inc305.32M
ARDTArdent Health Inc2.55B
EHCEncompass Health Corp13.88B
DVADaVita Inc11.23B
ENSGEnsign Group Inc10.78B
LFSTLifeStance Health Group Inc5.43B
SGRYSurgery Partners Inc3.47B

Insider trading

10 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Singer Maria RudermanDirectorMar 12 '26Option Exercise138.802,500347,00010,384Mar 13 04:48 PM
Miller Marc DPresident and CEOMar 12 '26Option Exercise145.77100,42514,638,889411,721Mar 13 04:32 PM
FILTON STEVEExecutive Vice President & CFOMar 12 '26Option Exercise146.1483,23712,164,529201,738Mar 13 04:29 PM
SUSSMAN ELLIOT J MD MBADirectorMar 13 '26Option Exercise138.801,250173,5007,363Mar 13 04:11 PM
SUSSMAN ELLIOT J MD MBADirectorMar 11 '26Option Exercise138.801,250173,5007,363Mar 13 04:11 PM
SUSSMAN ELLIOT J MD MBADirectorMar 13 '26Sale193.3735668,8416,113Mar 13 04:11 PM
SUSSMAN ELLIOT J MD MBADirectorMar 11 '26Sale186.3531859,2586,113Mar 13 04:11 PM
ELLIOT SUSSMANDirectorMar 13 '26Proposed Sale193.3735668,841Mar 13 04:06 PM
ELLIOT SUSSMANDirectorMar 11 '26Proposed Sale186.3531859,258Mar 11 04:55 PM
MILLER ALAN BExecutive ChairmanMar 10 '26Option Exercise146.14132,71219,394,9681,878,743Mar 11 04:06 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.94B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFATU.S. Targeted Value Portfolio-ETF Class Shares-
DFSVUS Small Cap Value Portfolio ETF Class Shares-
IVViShares Core S&P 500 ETFAUM: 871.38B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B

News

latest 14 of 206
  • Healthcare Stocks Bounce on Midterm Results. A Bull Market Case Is Developing. (Barrons.com) +10.91%
  • Hospital stocks rally while drugmakers brace for scrutiny. Here's what the Democratic wave means for healthcare. (MarketWatch)
  • Health insurers, hospitals rally after sweeping midterm win for Democrats (Reuters)
  • Election Odds Favor a Blue Wave. These Stocks Could Pop. (Barrons.com)
  • Investors Are Betting a Blue Wave Will Help Hospitals. Don't Count on It. (The Wall Street Journal)
  • Loading…
  • Universal Health Services, Inc. to Present at The UBS Global Healthcare Conference (GlobeNewswire)
  • Softer surgery volumes, hospital woes dampened UHS Q3 earnings (Healthcare Dive)
  • Universal Health Services: Q3 Earnings Snapshot (Associated Press)
  • Universal Health Services Misses As Volume Surge Collides With Pricing Erosion, Low-End Guidance And Newly Quantified 2027 Headwinds (Earnings Whispers)
  • Universal Health Services falls 3% on legal settlement concerns (Investing.com)
  • Universal Health Services, Inc. Announces Financial Results for the Three and Nine-Month Periods Ended September 30, 2026 (GlobeNewswire)
  • Universal Health Services, Inc. Announces Date and Time Change for Third Quarter 2026 Earnings Release and Conference Call (GlobeNewswire)
  • Universal Health Services, Inc. Announces Date for Third Quarter 2026 Earnings Release and Conference Call (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-275.2205.1925.2204,7334,71017
2026Q22026-07-275.9805.9405.9834,6384,57917
2026Q12026-04-275.6205.4095.6544,4954,38816
2025Q42026-02-255.8805.8607.0614,4864,50516
2025Q32025-10-275.6904.8785.8584,4954,33617
2025Q22025-07-285.3504.9175.4354,2844,23817
2025Q12025-04-284.8404.3524.7964,1004,15517
2024Q42025-02-264.9204.1604.9564,1144,00616
2024Q32024-10-243.7103.7173.7993,9633,90415
2024Q22024-07-244.3103.3034.2573,9083,86516
2024Q12024-04-243.7003.1463.8233,8443,77615
2023Q42024-02-273.1302.8913.1563,7043,66214
2023Q32023-10-252.5502.3702.3983,5633,54315
2023Q22023-07-252.5302.4342.4183,5483,50216
2023Q12023-04-252.3402.1952.2803,4683,44817
2022Q42023-02-273.0202.9622.4333,4473,39615

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY9.5309.4768.30510,77210,753
2019FY9.9909.7859.12911,37811,365
2020FY11.12010.32011.02911,55911,458
2021FY11.82011.73811.82412,64212,499
2022FY9.8809.8719.14113,39913,351
2023FY10.54010.28110.23214,28214,243
2024FY16.61015.91816.82115,82815,716
2025FY21.74021.74123.10017,36517,372
2026FY-22.399--18,611
2027FY-22.982--19,475
2028FY-24.845--20,324
2029FY-26.150--21,202

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0915224,7524,6414,844
2026Q4S2026-11-0615224,7554,6414,844
2026Q4S2026-11-0315224,7564,6414,844
2026Q4S2026-11-0215224,7564,6414,844
2026Q4S2026-10-3015224,7554,6414,844
2026Q4S2026-10-2815224,7544,6414,844
2026Q4S2026-10-2715004,7584,5994,931
2026Q4S2026-10-1415004,7584,5994,931
2026Q4S2026-10-1215014,7584,5994,931
2026Q4S2026-10-1115114,7584,5994,931
2026Q4S2026-10-0915324,7584,5994,931
2026Q4S2026-09-1815324,7584,5994,931
2026Q4S2026-09-1715334,7584,5994,931
2026Q4S2026-09-0115334,7594,5994,931

Estimate history

EPS, annual7.8068.3059.12911.02911.8249.14110.23216.82123.09623.9172
Period201720182019202020212022202320242025TTM
EPS, quarterly3.7994.9564.7965.4355.8587.0615.6545.9835.219
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual10407.26510772.27811378.25911558.89712642.11713399.3714281.97615827.93517364.82918352.59
Period201720182019202020212022202320242025TTM
Sales, quarterly3963.0274113.7224099.724283.8164495.2454486.0484495.1824638.0124733.352
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual94.22891.3586.70785.06377.09170.62967.18264.97761.06457.652
Period201720182019202020212022202320242025MRQ
Shares, quarterly65.96664.97764.4463.63962.48261.06460.53658.93757.652
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue18,352.5917,364.8315,827.9314,281.9813,399.3712,642.1211,558.9011,378.2610,772.28
Cost of Goods Sold Incl. D&A16,361.3815,370.8114,146.1213,106.5912,338.2611,264.6310,201.9110,064.729,544.98
Gross Profit1,991.221,994.021,681.811,175.381,061.111,377.481,356.991,313.541,227.30
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income1,991.221,994.021,681.811,175.381,061.111,377.481,356.991,313.541,227.30
Interest Expense176.77157.26187.53207.25127.2785.27109.09166.60163.21
Unusual Expense53.9553.95-62.3445.7557.5531.22-1.3697.6352.04
Net Income Before Taxes1,943.591,972.141,497.94940.43866.261,293.311,252.081,066.341,034.53
Income Taxes459.16460.96334.83221.12209.28305.68299.29238.79236.64
Consolidated Net Income1,484.441,511.181,163.06719.00656.23985.57949.81825.51796.79
Net Income From Continuing Operations1,461.751,488.801,142.05717.49674.86989.53940.97812.83778.61
Net Income1,461.751,488.801,142.10717.49674.86989.53940.97812.83778.61
EPS (Recurring)25.3523.6816.1810.699.6912.0810.989.908.69
EPS (Basic, Before Extraordinaries)24.1623.4217.1610.359.2311.9911.109.168.35
EPS (Diluted)23.9223.1016.8210.239.1411.8211.039.138.31
EBITDA2,652.162,612.762,266.641,743.421,642.971,910.701,867.481,803.931,680.34
Non-Operating Income (Expense)183.09189.33-58.6918.04-10.0332.322.8217.0322.48
Other After Tax Adjustments0.000.00-0.05-0.31-0.75-2.06-2.98-2.03-1.09
Stock Option Compensation Expense94.7374.2277.3568.1667.4543.2939.9043.8848.24
Price To Earnings Ratio8.178.1711.9316.0014.5010.9712.4915.7314.05
Price To Sales Ratio0.560.810.770.750.780.861.021.121.01
Gross Margin10.8511.4810.638.237.9210.9011.7411.5411.39
Operating Margin10.8511.4810.638.237.9210.9011.7411.5411.39
Net Margin7.968.577.225.025.047.838.147.147.23
Shares Outstanding57.6561.0664.9867.1870.6377.0985.0686.7191.35
Market Capitalization11,516.7411,516.7411,835.7810,578.2810,061.0310,421.6711,684.9612,564.6310,783.29

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue4,733.354,638.014,495.184,486.054,495.244,283.824,099.724,113.72
Cost of Goods Sold Incl. D&A4,278.904,121.343,992.323,968.823,973.563,783.553,644.893,641.23
Gross Profit454.45516.67502.86517.23521.69500.27454.82472.49
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income454.45516.67502.86517.23521.69500.27454.82472.49
Interest Expense57.0640.0137.2242.4638.6235.7140.4640.11
Unusual Expense0.000.000.0053.950.000.004.30-52.63
Net Income Before Taxes413.91479.13469.12581.44496.89473.38420.43438.31
Income Taxes100.58114.54110.44133.60117.78110.7798.80101.26
Consolidated Net Income313.33364.59358.68447.84379.11362.61321.63337.05
Net Income From Continuing Operations308.68358.45348.68445.94372.96353.22316.68332.40
Net Income308.68358.45348.68445.94372.96353.22316.68332.40
EPS (Recurring)5.225.985.657.665.865.434.844.41
EPS (Basic, Before Extraordinaries)5.256.015.717.195.925.494.875.07
EPS (Diluted)5.225.985.657.065.865.434.804.96
EBITDA629.29684.01658.29680.57676.75652.27603.17619.27
Non-Operating Income (Expense)16.532.463.48160.6213.818.8310.37-46.70
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense20.4517.6117.5439.1319.3818.6316.8120.65
Price To Earnings Ratio8.176.197.7310.3610.7710.1711.1611.93
Price To Sales Ratio0.560.490.620.790.770.720.770.76
Gross Margin9.6011.1411.1911.5311.6111.6811.0911.49
Operating Margin9.6011.1411.1911.5311.6111.6811.0911.49
Net Margin6.527.737.769.948.308.257.728.08
Shares Outstanding57.6558.9460.5461.0662.4863.6464.4464.98
Market Capitalization11,516.749,001.1410,932.6913,622.4313,010.3011,673.3812,213.8811,835.78

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments137.80125.98119.44102.82115.301,224.4961.27105.2274.42
Short Term Receivables2,602.432,177.752,238.262,017.721,746.631,728.931,560.851,509.911,500.90
Inventories232.11220.94216.99218.52206.84190.42159.89148.21136.18
Other Current Assets435.57291.61236.66198.28194.78138.03133.93174.4786.50
Total Current Assets3,407.912,816.292,811.352,537.342,263.563,281.871,915.931,937.801,798.00
Net Property, Plant & Equipment7,382.346,990.946,558.496,373.116,241.755,709.645,343.224,847.944,571.84
Total Investments and Advances346.23318.73308.44300.37247.15211.73183.65101.9711.20
Intangible Assets4,066.094,009.154,009.433,987.564,043.663,965.303,953.424,017.634,045.16
Deferred Tax Assets500.01502.44474.87462.7345.7122.6916.195.283.01
Other Assets254.50216.19194.27227.42251.71285.66255.84354.87332.62
Total Assets15,957.0814,853.7414,356.8513,888.5213,093.5413,476.8811,668.2511,265.4810,761.83
Short Term Debt Incl. Current Port. of LT Debt821.39114.71198.29149.22112.89391.79143.9963.45545.62
Accounts Payable750.13632.00613.97636.60658.90570.52446.96445.65441.98
Income Tax Payable1.9314.222.054.6110.7244.422.522.4318.33
Other Current Liabilities1,666.141,449.481,199.041,123.991,201.601,474.30969.93937.21842.10
Total Current Liabilities3,239.602,210.412,013.351,914.421,984.112,481.041,563.391,448.741,848.03
Long Term Debt4,345.114,840.725,168.345,122.064,446.503,802.564,166.653,935.193,494.39
Provision for Risks Charges0.000.000.000.00274.69189.78199.82204.890.00
Deferred Tax Liabilities435.14383.99389.25394.330.005.5825.0749.6654.96
Other Liabilities527.83655.81584.01487.67190.07591.39130.11156.92306.30
Total Liabilities8,547.688,090.928,154.947,918.486,895.377,070.346,085.055,795.405,703.69
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity7,275.796,666.216,149.005,920.586,089.666,317.155,504.105,389.264,989.51
Total Shareholders Equity7,275.796,666.216,149.005,920.586,089.666,317.155,504.105,389.264,989.51
Accumulated Minority Interest133.6296.6152.9149.46108.5189.3979.1080.8268.62
Total Equity7,409.416,762.826,201.915,970.056,198.176,406.545,583.205,470.095,058.14
Total Liabilities & Stockholders Equity15,957.0814,853.7414,356.8513,888.5213,093.5413,476.8811,668.2511,265.4810,761.83
Book Value Per Share119.15102.5991.5383.8378.9974.2663.4859.0052.95
Tangible Book Value Per Share52.5640.8931.8527.3726.5427.6517.8815.0210.02
Full-Time Employees101,50099,00096,70093,80089,40089,00080,80078,70076,600
Price to Book Ratio1.481.791.721.721.641.852.261.982.21
Return on Assets9.667.825.085.007.457.487.097.077.13
Return on Equity21.3617.8211.8911.2415.9515.9214.9215.0015.79
Return on Invested Capital12.819.926.346.119.399.308.408.358.86
Quick Ratio0.981.171.291.211.041.251.121.240.90
Current Ratio1.051.271.401.331.141.321.231.340.97

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income1,484.441,511.181,163.11719.31656.98987.63952.79827.54797.88
Depreciation660.94618.74584.83568.04581.86533.21510.49490.39453.08
Other Funds (Non Cash)2.4110.3792.5981.47143.5199.7469.16159.52116.11
Funds from Operations2,147.792,140.291,840.531,368.821,382.361,620.581,532.441,477.461,367.06
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-91.61-275.89226.57-101.02-386.33-736.89827.73-38.99-26.17
Income Taxes Payable55.59-21.4412.65-43.45-----
Cash from Operating Activities2,056.181,864.402,067.101,267.80996.02883.702,360.171,438.471,340.89
Capital Expenditures-940.95-1,015.15-943.81-743.05-734.00-855.66-734.21-655.51-701.21
Net Assets From Acquisitions-1,002.88-47.80-19.00-3.73-68.81-105.42-52.01-8.01-110.46
Sale of Fixed Assets and Businesses30.7715.8638.5624.1912.0038.6226.1310.9013.50
Purchase or Sale of Investments-2.86-52.2112.86-40.7094.911.36-24.41-34.34-15.33
Purchase of Investments-2.86-52.210.00-40.700.000.00-24.41-34.34-15.33
Sale Or Maturity of Investments--12.860.0094.911.360.000.000.00
Other Uses-31.39-34.530.000.000.000.00-0.100.000.00
Other Sources63.2063.220.280.020.1019.830.000.000.10
Cash from Investing Activities-1,867.90-1,070.62-911.11-763.27-695.80-901.27-784.60-686.96-813.40
Cash Dividends Paid-48.92-51.27-53.35-55.48-58.45-65.90-17.34-53.00-37.34
Change in Capital Stock-1,064.33-951.22-655.68-533.71-818.85-1,207.50-194.40-759.70-387.23
Repurchase of Common Pref Stock-1,081.87-967.95-670.75-547.36-832.92-1,220.88-206.72-770.50-397.43
Sale of Common Pref Stock17.5516.7315.0713.6514.0713.3712.3210.8110.20
Proceedsfrom Stock Options17.5516.7315.0713.6514.0713.3712.3210.8110.20
Issuance or Reduction of Debt, Net1,017.13241.65-442.3299.31612.79198.34-171.27-17.92-53.04
Change in Long Term Debt1,017.13241.65-442.3299.31612.79198.34-171.27-17.92-53.04
Issuance of Long Term Debt1,861.33285.152,197.68184.79702.163,236.20791.3039.22777.46
Reduction of Long Term Debt-844.20-43.50-2,640.00-85.48-89.37-3,037.87-962.57-57.14-830.50
Net Financing Active Other Cash Flow-5.6711.116.47-4.07-5.39-7.08-19.80-15.86-14.60
Other Financing Activities Uses-14.66-11.73-6.51-6.83-5.39-7.08-19.80-15.86-14.60
Cash from Financing Activities-101.79-749.73-1,144.88-493.94-269.90-1,082.14-402.82-846.48-492.20
Exchange Rate Effect-0.512.52-0.833.06-8.42-0.500.740.96-2.90
Net Change in Cash85.9846.5710.2813.6321.90-1,100.221,173.49-94.0232.39
Free Cash Flow1,115.23849.251,123.29524.74262.0228.041,628.86804.37675.93
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow9.6717.6111.3922.7851.10-7.3017.0017.11
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments168.75138.80119.03137.80112.89137.59
Short Term Receivables2,813.702,801.112,745.092,602.432,585.342,302.25
Inventories235.56234.09229.41232.11226.66222.78
Other Current Assets462.15505.32406.17435.57333.08327.36
Total Current Assets3,680.163,679.323,499.703,407.913,257.962,989.98
Net Property, Plant & Equipment7,639.707,508.387,438.967,382.347,355.467,272.82
Total Investments and Advances462.70465.69459.26346.23348.61334.23
Intangible Assets4,736.953,981.713,980.664,066.093,989.373,977.98
Deferred Tax Assets95.9963.7268.34500.01145.32147.68
Other Assets570.27236.65234.22254.50247.20262.88
Total Assets17,185.7715,935.4915,681.1415,957.0815,343.9214,985.58
Short Term Debt Incl. Current Port. of LT Debt159.64842.77829.14821.39813.52114.06
Accounts Payable2,521.452,451.122,356.34750.132,332.422,197.09
Income Tax Payable6.273.7058.591.9313.255.37
Other Current Liabilities0.000.060.001,666.140.000.54
Total Current Liabilities2,687.363,297.663,244.083,239.603,159.192,317.07
Long Term Debt6,016.684,419.404,296.674,345.114,297.404,893.93
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities3.233.233.23435.14--
Other Liabilities736.43559.96532.68527.83589.85629.49
Total Liabilities9,443.708,280.258,076.668,547.688,046.447,840.49
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity7,596.857,513.817,464.867,275.797,169.697,030.05
Total Shareholders Equity7,596.857,513.817,464.867,275.797,169.697,030.05
Accumulated Minority Interest145.22141.43139.62133.62127.79115.03
Total Equity7,742.077,655.247,604.487,409.417,297.487,145.08
Total Liabilities & Stockholders Equity17,185.7715,935.4915,681.1415,957.0815,343.9214,985.58
Book Value Per Share131.77127.49123.31119.15114.75110.47
Tangible Book Value Per Share49.6159.9357.5652.5650.9047.96
Full-Time Employees---101,500--
Price to Book Ratio1.481.211.501.901.851.72
Return on Assets8.999.879.959.669.268.68
Return on Equity19.8020.9921.3421.3619.9718.66
Return on Invested Capital2.273.002.963.843.252.96
Quick Ratio1.281.041.010.980.961.19
Current Ratio1.371.121.081.051.031.29

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income313.33364.59358.68447.84379.11362.61
Depreciation174.84167.34155.43163.33155.06152.00
Other Funds (Non Cash)25.6322.3817.46-63.0524.8826.95
Funds from Operations513.80554.30531.56548.12559.04541.56
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital122.75-111.00-129.9326.58-178.377.42
Income Taxes Payable7.99-75.01104.7717.8516.63-144.55
Cash from Operating Activities636.56443.30401.63574.69380.68548.98
Capital Expenditures-214.94-227.63-217.16-281.22-228.89-266.01
Net Assets From Acquisitions-998.000.00-4.86-0.03-39.460.00
Sale of Fixed Assets and Businesses2.151.4314.3012.880.002.98
Purchase or Sale of Investments4.21-2.7114.72-2.8617.05-42.71
Purchase of Investments0.000.000.00-2.8617.05-42.71
Sale Or Maturity of Investments4.21-2.7114.72-0.000.00
Other Uses-5.57-5.35-4.61-15.85-18.21-0.20
Other Sources0.030.030.0363.120.100.00
Cash from Investing Activities-1,212.12-234.23-197.58-223.97-269.41-305.94
Cash Dividends Paid-11.79-11.79-12.97-12.37-12.47-12.90
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-240.99-315.88-160.07-347.40-233.42-150.68
Repurchase of Common Pref Stock-245.26-320.75-163.85-352.01-237.40-155.16
Sale of Common Pref Stock4.284.883.784.613.984.48
Proceedsfrom Stock Options4.284.883.784.613.984.48
Issuance or Reduction of Debt, Net859.41141.58-44.6960.84104.76-67.29
Change in Long Term Debt859.41141.58-44.6960.84104.76-67.29
Issuance of Long Term Debt1,486.15298.590.0476.55114.00-57.85
Reduction of Long Term Debt-626.74-157.01-44.73-15.71-9.24-9.44
Net Financing Active Other Cash Flow-0.90-3.40-4.162.796.603.21
Other Financing Activities Uses-1.44-3.98-7.91-1.32-0.79-3.71
Cash from Financing Activities605.73-189.49-221.89-296.13-134.52-227.65
Exchange Rate Effect0.040.25-0.920.13-1.542.29
Net Change in Cash30.2019.83-18.7754.72-24.8017.67
Free Cash Flow421.61215.67184.47293.47151.79282.96
Price to Free Cash Flow9.6711.1912.8017.2614.2013.87

Revenue breakdown

Managed Care2024: 4.50B 2025: 4.90B
Managed Medicaid2024: 2.30B 2025: 2.48B
Managed Medicare2024: 1.88B 2025: 2.08B
Medicaid2024: 2.25B 2025: 2.69B
Medicare2024: 1.67B 2025: 1.86B
Other Non Patient2024: 1.23B 2025: 1.11B
Other Patient Revenue And Adjustments Net2024: 1.11B 2025: 1.24B
U K2024: 880.15M 2025: 1.00B
United States2024: 15.83B 2025: 17.36B
Acute Care Hospital Services2024: 8.94B 2025: 9.93B
Behavioral Health Services2024: 6.87B 2025: 7.43B
Other Segments2024: 10.56M 2025: 13.42M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.22%2.5M48.8M696.20K
2026-10-155.41%2.6M48.8M766.02K
2026-09-305.24%2.6M48.8M825.48K
2026-09-155.58%2.7M48.8M835.49K
2026-08-315.28%2.6M48.8M908.69K
2026-08-145.25%2.6M48.9M1.02M
2026-07-315.95%3.0M50.4M1.08M
2026-07-156.75%3.4M50.4M1.03M
2026-06-305.99%3.0M50.4M974.06K
2026-06-155.14%2.6M50.4M936.15K
2026-05-295.98%3.0M50.4M898.44K
2026-05-156.02%3.0M50.4M833.53K
2026-04-305.50%2.8M50.9M777.58K
2026-04-154.09%2.1M51.0M735.97K
2026-03-314.13%2.1M51.2M781.75K
2026-03-133.47%1.8M51.2M783.57K
2026-02-273.95%2.0M51.2M747.93K
2026-02-133.68%1.9M52.6M720.36K
2026-01-303.84%2.0M52.4M702.13K
2026-01-153.80%2.0M52.6M708.80K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call12073.0076.100.001.9950.000.000.990-0.0720.008
call12568.4070.800.001.7460.000.000.989-0.0720.009
call13063.6066.200.001.7460.000.000.989-0.0720.009
call13558.4061.200.001.5190.000.000.988-0.0720.010
call14053.6055.900.001.4750.000.000.986-0.0710.011
call14548.3051.200.001.2420.000.000.985-0.0700.011
call15043.1046.400.001.0950.000.000.984-0.0700.012
call15538.9041.300.001.1270.000.000.982-0.0690.014
call16033.2036.2030.130.98557.000.000.979-0.0680.015
call16529.0030.7036.300.7622.000.000.971-0.0790.020
call17023.6026.006.200.71466.000.000.956-0.0990.029
call17519.2021.0022.400.62928.000.000.926-0.1300.043
call18013.7016.6016.480.56718.000.000.830-0.2540.077
call1859.8012.2015.150.51579.000.000.734-0.3280.100
call1906.708.207.700.45675.001.000.644-0.3130.114
call1954.205.005.380.4221260.000.507-0.3340.122
call2001.602.803.730.41093.000.000.359-0.2880.114
call2100.200.850.750.42468.001.000.144-0.1730.069
call2200.000.550.400.52516.000.000.078-0.1320.045
call2300.001.750.000.6700.000.000.064-0.1440.038
call2400.001.750.000.8000.000.000.055-0.1530.034
call2500.001.750.000.9200.000.000.049-0.1610.031
call2600.002.150.031.0331.000.000.045-0.1670.029
put1200.002.150.091.38811.000.00-0.010-0.0610.008
put1250.000.800.151.27922.000.00-0.011-0.0600.009
put1300.000.750.251.1816.000.00-0.011-0.0600.009
put1350.000.750.351.0811540.00-0.012-0.0590.010
put1400.000.750.410.9891420.00-0.013-0.0580.011
put1450.000.750.550.89710.000.00-0.015-0.0570.011
put1500.000.750.580.80511.000.00-0.016-0.0550.012
put1550.000.750.140.7174210.00-0.018-0.0540.014
put1600.000.150.150.63149.000.00-0.020-0.0520.015
put1650.050.200.050.57178.001.00-0.029-0.0630.020
put1700.150.300.400.5192010.00-0.045-0.0820.029
put1750.150.500.340.4804970.00-0.074-0.1130.043
put1800.051.601.450.54896.000.00-0.175-0.2390.078
put1850.553.101.330.5811060.00-0.267-0.3100.100
put1902.053.8017.200.4892110.00-0.356-0.2940.114
put1953.906.700.000.5350.000.00-0.495-0.3140.122
put2007.109.300.000.5070.000.00-0.633-0.2810.115
put21015.0017.500.000.5810.000.00-0.857-0.1510.069
put22024.4027.100.000.7680.000.00-0.922-0.1100.045
put23033.5036.800.000.8970.000.00-0.936-0.1210.038
put24044.1046.300.000.9350.000.00-0.945-0.1290.034
put25053.9056.300.001.1040.000.00-0.950-0.1350.031
put26064.2066.400.001.2530.000.00-0.955-0.1400.029

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-278-KCurrent report2026-10-27SEC
2026-10-19SCHEDULE 13GSEC
2026-10-08SCHEDULE 13GSEC
2026-08-218-KCurrent report2026-08-20SEC
2026-08-18S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-178-KCurrent report2026-08-17SEC
2026-08-138-KCurrent report2026-08-11SEC
2026-08-13424B5SEC
2026-08-12FWPFiling under Securities Act Rule 163/433 of free writing prospectuses.SEC
2026-08-10424B5SEC
2026-08-07POSASRPost-effective amendment to an automatic shelf registration statement of Form S-3ASR or Form F-3ASRSEC
2026-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-06SCHEDULE 13G/ASEC
2026-07-288-KCurrent report2026-07-27SEC
2026-07-218-KCurrent report2026-07-20SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-228-KCurrent report2026-05-20SEC
2026-05-218-KCurrent report2026-05-18SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-30SCHEDULE 13GSEC
2026-04-288-KCurrent report2026-04-27SEC
2026-04-248-KCurrent report2026-04-22SEC
2026-04-09DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-09ARSAnnual report to security holders. 2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-0300128.10K2
2026-020000
2026-010000
2025-120000
2025-1100852.34K1

Institutional holders

Manager% owned
First Eagle Investment Management, LLC7.75%
BlackRock, Inc.6.71%
VANGUARD CAPITAL MANAGEMENT LLC5.60%
DIMENSIONAL FUND ADVISORS LP4.55%
PZENA INVESTMENT MANAGEMENT LLC4.42%
VANGUARD PORTFOLIO MANAGEMENT LLC4.05%
FMR LLC3.63%
STATE STREET CORP3.47%
GEODE CAPITAL MANAGEMENT, LLC3.38%
Invesco Ltd.3.22%

Funds

Fund% owned
Navigator Tactical Fixed Income Fund88.26%
Bond Fund43.62%
First Trust Enhanced Short Maturity ETF41.30%
Janus Henderson Short Duration Income ETF38.70%
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND29.29%
VANGUARD TOTAL BOND MARKET II INDEX FUND23.99%
Guggenheim Total Return Bond Fund22.88%
Invesco BulletShares 2026 Corporate Bond ETF20.70%
Fidelity Investment Grade Bond Fund17.72%
Virtus Newfleet Multi-Sector Short Term Bond Fund16.93%

OakChart. UHS. Cached 15 minutes.